## **Core Concept**
Depolarizing neuromuscular blocking drugs act by mimicking the action of acetylcholine at the nicotinic receptors of the neuromuscular junction, leading to initial muscle fasciculations followed by muscle paralysis. This class of drugs is characterized by their ability to depolarize the muscle membrane. **Succinylcholine** is a well-known example of a depolarizing neuromuscular blocking agent.

## **Why the Correct Answer is Right**
The correct answer, , highlights that depolarizing neuromuscular blockers work by persistent depolarization of the muscle membrane, which leads to desensitization of the acetylcholine receptors and thus prevents further depolarization and muscle contraction. This mechanism results in flaccid paralysis. The prototype drug, succinylcholine, acts rapidly and has a short duration of action due to its quick hydrolysis by plasma cholinesterase.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because depolarizing agents do not work by competitively blocking acetylcholine receptors; that is the mechanism of non-depolarizing neuromuscular blockers.
- **Option B:** This option is incorrect as depolarizing neuromuscular blockers do not cause hyperpolarization; they cause depolarization.
- **Option C:** While not explicitly provided, any statement contradicting the mechanism of depolarization or the effects of depolarizing agents would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that **succinylcholine** can cause **hyperkalemia** due to the depolarization of muscle cells, which can be particularly dangerous in patients with burns, trauma, or certain neuromuscular diseases. This side effect makes it crucial to use with caution in specific patient populations.

## **Correct Answer:** . Succinylcholine.